Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Clorox Co (CLX) vs Quest Diagnostics Inc (DGX) Price & Performance

Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Clorox Co vs Quest Diagnostics Inc — how do they compare? Clorox Co trades at $106.16 (market cap $13.09B), while Quest Diagnostics Inc trades at $238.51 (market cap $26.21B). The key difference: Quest Diagnostics Inc is far larger — about 2× Clorox Co's market cap, and Clorox Co pays the higher dividend (4.62%). Which is the better fit depends on your goals.

CLXDGX
Market Cap
$13.09B$26.21B
Sector
Consumer StaplesHealth
52-Week High
$127.16$238.50
52-Week Low
$86.12$173.49
Enterprise Value
$18.47B$31.97B
Dividend Yield
4.62%1.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Clorox Co

CLX trades at $106.30, down 1.3% today, with a bullish technical signal from moving averages but overbought RSI readings. Recent Q2 2026 earnings beat estimates with EPS of $1.66, though Q4 2025 missed. The company reported FY2025 revenue of $7.10B and net income of $810M, with improving margins. A dividend increase to $1.25 per share was announced, payable in August 2026.

Outlook is mixed: strong profitability and dividend support value, but high P/E of 22.51 and modest revenue growth pose valuation concerns. Analyst consensus is cautious with a $97.50 price target below current levels. Risks include inflation pressures and competitive threats from private labels, limiting near-term upside potential.

Quest Diagnostics Inc

Quest Diagnostics (DGX) trades at $237.24, down 0.16% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $3.12 and raising its full-year outlook, driven by robust testing demand. Revenue grew to $11.04B in 2025, with net income of $992M, though margins face pressure from lower-margin deals and rising costs.

The outlook is positive due to raised guidance and AI integration enhancing efficiency, but risks include debt levels and margin compression. Analysts maintain a cautious buy stance with a $249.50 price target, indicating modest upside potential from current levels amid competitive and cost challenges.

Returns comparison

Trailing returns across standard periods

About Clorox Co

With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.

Read more on CLX

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX